IE
ANIX icon

Israel Englander’s Anixa Biosciences ANIX Stock Holding History

Israel Englander’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,177
Closed -$38K – 5676
2025
Q4 		$38K Buy
+12,177
New +$49.9K ﹤0.01% 5764
2025
Q3 		– Sell
-10,582
Closed -$34.9K – 5996
2025
Q2 		$34.9K Buy
+10,582
New +$30.2K ﹤0.01% 5642
2025
Q1 		– Sell
-11,028
Closed -$25.6K – 5815
2024
Q4 		$25.6K Buy
+11,028
New +$34.2K ﹤0.01% 5684
2022
Q4 		– Sell
-36,249
Closed -$178K – 6548
2022
Q3 		$178K Buy
36,249
+17,051
+89% +$69.1K ﹤0.01% 5719
2022
Q2 		$59K Sell
19,198
-4,979
-21% -$15.7K ﹤0.01% 6139
2022
Q1 		$66K Buy
24,177
+8,465
+54% +$24.8K ﹤0.01% 6311
2021
Q4 		$47K Buy
+15,712
New +$63.5K ﹤0.01% 6489
2020
Q3 		– Sell
-39,304
Closed -$120K – 4404
2020
Q2 		$120K Buy
+39,304
New +$81.5K ﹤0.01% 3951
2016
Q2 		– Sell
-11,481
Closed -$35K – 3146
2016
Q1 		$35K Sell
11,481
-2,628
-19% -$7.54K ﹤0.01% 3168
2015
Q4 		$42K Sell
14,109
-21,892
-61% -$76.8K ﹤0.01% 3319
2015
Q3 		$171K Buy
+36,001
New +$167K ﹤0.01% 3161

Other funds holding ANIX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $5.21B AUM 31.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Israel Englander's ANIX Position: Q1 2026 in Review

Israel Englander sold out of Anixa Biosciences (ANIX) in Q1 2026, closing a stake of 12,177 shares — an estimated $38K sold.

Israel Englander first reported a position in ANIX in Q3 2015 and held it in 11 quarters. The position peaked at $178K in Q3 2022. 60 funds tracked by Wall St. Rank hold ANIX as of Q1 2026.

  • Israel Englander reported no remaining Anixa Biosciences position as of Q1 2026 after selling out during the quarter.
  • Israel Englander sold 12,177 Anixa Biosciences shares in Q1 2026, an estimated $38K.
  • Israel Englander first reported a position in Anixa Biosciences in Q3 2015 and held it in 11 quarters.
  • Israel Englander's Anixa Biosciences position peaked at $178K in Q3 2022.
  • 60 funds tracked by Wall St. Rank held Anixa Biosciences as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.